Viewing Study NCT04749641



Ignite Creation Date: 2024-05-06 @ 3:45 PM
Last Modification Date: 2024-10-26 @ 1:56 PM
Study NCT ID: NCT04749641
Status: RECRUITING
Last Update Posted: 2023-07-27
First Post: 2021-02-03

Brief Title: Neoantigen Vaccine Therapy Against H33-K27M Diffuse Intrinsic Pontine Glioma
Sponsor: Yang Zhang
Organization: Beijing Tiantan Hospital

Study Overview

Official Title: Enhanced Histone H33-K27M Neoantigen Vaccine Therapy Against Diffuse Intrinsic Pontine Glioma ENACTING- A Phase I Clinical Trial
Status: RECRUITING
Status Verified Date: 2023-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ENACTING
Brief Summary: Diffuse intrinsic pontine gliomas DIPGs which diffusely occupy the pons of brainstem are the deadliest primary brain cancer in children Biopsy for pathology plus radiotherapy remains the current standard-of-care treatment that is minimal effective Thus the median overall survival after diagnosis is just 10 months Recent studies have identified a lysine 27-to-methionine K27M somatic mutation at histone H3 variant H33 as a feature mutation in DIPGs Several preclinical studies have already demonstrated H33-K27M as a promising target for immunotherapy The researched vaccine is a cancer-treatment vaccine containing an H33-K27M targeted neoantigen peptide that can be taken up by antigen-presenting cells APCs APCs can present the peptide with the major histocompatibility complex MHC molecules on cell surface thereby activating neoantigen-specific T cells and triggering corresponding cytotoxic T cell immune responses to eliminate H33-K27M-expressing DIPG cells The main goal of this study is investigating the safety and preliminary efficacy of the vaccine in treating newly-diagnosed DIPGs when the vaccine is administered in combination with the standard-of-care treatment
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None